Literature DB >> 3693983

Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma.

J Overgaard1, M Overgaard.   

Abstract

One hundred and fifteen cutaneous or lymph node metastases from malignant melanoma were treated with three fractions of irradiation alone in 8 days (62 tumours) or followed by heat either immediately (simultaneous treatment, 26 tumours) or after an interval of 3-4 h (sequential therapy, 27 tumours). In addition, three tumours were treated unsuccessfully with heat alone. The total doses of radiation varied between 15 and 30 Gy, allowing a dose-response analysis. For irradiation alone the isoeffective dose to obtain 50 per cent complete response (TCD50) was 26.3 Gy. Addition of heat reduced the TCD50 significantly (p less than 0.05) with a thermal enhancement ratio (TER) of 1.43 for simultaneous treatment and 1.24 for sequential therapy. Also the persistent local control at 18 months was improved by hyperthermia (56 per cent versus 86 per cent, p less than 0.05). However, simultaneous treatment also enhanced the acute skin response to the same extent as the tumour (TER 1.42 for severe erythema). This schedule thus gave no therapeutic gain. In contrast, no normal tissue enhancement was found after sequential treatment (TER 1.02). Such a treatment schedule resulted in a significantly improved therapeutic ratio of 1.22. This effect was especially prominent in larger tumours (if sufficiently heated) and an analysis corrected for volume showed a TER of 1.51. A special analysis was performed in patients with multiple lesions. 15 pairs of tumours were given the same radiation dose, with or without hyperthermia. Out of these, 11 showed a better response, three showed the same response, and only in one pair was the best response in the tumour obtained by radiation alone.

Entities:  

Mesh:

Year:  1987        PMID: 3693983     DOI: 10.3109/02656738709140422

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  7 in total

1.  Histopathological findings in human choroidal melanomas after transpupillary thermotherapy.

Authors:  J G Journée-de Korver; J A Oosterhuis; D de Wolff-Rouendaal; H Kemme
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

2.  Adaptive Real-Time Closed-Loop Temperature Control for Ultrasound Hyperthermia Using Magnetic Resonance Thermometry.

Authors:  L Sun; C M Collins; J L Schiano; M B Smith; N B Smith
Journal:  Concepts Magn Reson Part B Magn Reson Eng       Date:  2005-10-28       Impact factor: 1.176

Review 3.  Hyperthermia in cancer therapy: where are we today and where are we going?

Authors:  R A Steeves
Journal:  Bull N Y Acad Med       Date:  1992 Mar-Apr

Review 4.  Ultrasound Hyperthermia Technology for Radiosensitization.

Authors:  Lifei Zhu; Michael B Altman; Andrei Laszlo; William Straube; Imran Zoberi; Dennis E Hallahan; Hong Chen
Journal:  Ultrasound Med Biol       Date:  2019-02-14       Impact factor: 2.998

5.  Concurrent versus sequential application of ferromagnetic hyperthermia and 125I brachytherapy of melanoma in an animal model.

Authors:  W F Mieler
Journal:  Trans Am Ophthalmol Soc       Date:  1997

6.  Treatment of malignant brain tumors with focused ultrasound hyperthermia and radiation: results of a phase I trial.

Authors:  A N Guthkelch; L P Carter; J R Cassady; K H Hynynen; R P Iacono; P C Johnson; E A Obbens; R B Roemer; J F Seeger; D S Shimm
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

7.  Feasibility of removable balloon implant for simultaneous magnetic nanoparticle heating and HDR brachytherapy of brain tumor resection cavities.

Authors:  Paul R Stauffer; Dario B Rodrigues; Robert Goldstein; Thinh Nguyen; Yan Yu; Shuying Wan; Richard Woodward; Michael Gibbs; Ilya L Vasilchenko; Alexey M Osintsev; Voichita Bar-Ad; Dennis B Leeper; Wenyin Shi; Kevin D Judy; Mark D Hurwitz
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.